Cytokinetics | CYTK - Pre Tax Profit


Cytokinetics reported $-206.03M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 3.98M 22.34M Mar/2026
Amgen USD 1.51B 2.41B Dec/2025
Arca Biopharma USD -29.58M 694K Dec/2025
Bayer EUR -3.37B 2.21B Dec/2025
Biogen USD 377.7M 433.7M Mar/2026
Brainstorm Cell Therapeutics USD -2.11M 797K Sep/2025
Bristol-Myers Squibb USD 1.47B 1.64B Dec/2025
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Cytokinetics USD -206.03M 23M Mar/2026
Eisai JPY -7.94B 29.94B Mar/2026
Eli Lilly USD 8.27B 1.03B Dec/2025
Exelixis USD 267.69M 15M Mar/2026
Geron USD -3.64M 27.5M Mar/2026
Halozyme Therapeutics USD 180.33M 281.18M Mar/2026
Ionis Pharmaceuticals USD -93M 135M Mar/2026
Ligand Pharmaceuticals USD 56.78M 84.36M Dec/2025
Merck USD 3.42B 3.32B Dec/2025
Novartis USD 3.84B 802M Mar/2026
Pfizer USD 5.18B 6.82B Mar/2026
Regeneron Pharmaceuticals USD 1.04B 719.6M Dec/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025